Senseonics Holdings, Inc.
A medical technology company that makes the Eversense line of implantable continuous glucose monitors for people with diabetes. Unlike skin-worn sensors that last days, Eversense's small sensor is placed under the skin of the upper arm by a healthcare professional and can work for up to a year. Founded in 1996 and based in Germantown, Maryland, the company was once called Sensors for Medicine and Science before renaming itself Senseonics in 2012 — a blend of "sense," "eon" (long time), and "-ics" nodding to its long-wear sensors.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| Sessa Capital IM, L.P. | 13GPassive | 9.9% | 12.44M | Aug 14, 2026 |
| John Petry | 13GPassive | 9.9% | 12.44M | Aug 14, 2026 |
| BlackRock, Inc. | 13GPassive | 6.6% | 2.76M | Jul 30, 2026 |
| ROBERT J. SMITH | 13G/APassive | 6.14% | 50.03M | Aug 8, 2025 |
| ENERGY CAPITAL, LLC | 13G/APassive | 6.1% | 49.70M | Aug 8, 2025 |
| PLATO & ASSOCIATES, LLC | 13G/APassive | 0.04% | 335.0K | Aug 8, 2025 |